Coinfection with Respiratory Pathogens in COVID-19 in Korea
Preprint
Abstract
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in upper and lower respiratory specimens and coinfection with other respiratory pathogens in patients with coronavirus disease 2019 (COVID-19) were investigated. From the study subjects (N = 258) retrospectively enrolled when confirmed as SARS-CoV-2 positive, nasopharyngeal (NPS), oropharyngeal swabs (OPS), and sputum specimens were restored for retesting SARS-CoV-2 and detecting respiratory pathogens. Majority of the study subjects (95.7%, N = 247) were confirmed as SARS-CoV-2 positive using NPS/OPS specimens, suggesting that the upper respiratory specimen is most valuable in detecting SARS-CoV-2. Coinfection rates in COVID-19 patients (N = 258) with respiratory pathogens were 9.7% (N = 25); 8.5% (N = 22) respiratory viruses and 1.2% (N = 3) Mycoplasma pneumoniae , an atypical bacterium. Of the respiratory virus coinfection cases (N = 22), 20 (90.9%) were co-infected with a single respiratory virus and 2 (0.8%) (metapneumovirus/adenovirus and rhinovirus/bocavirus 1/2/3/4) with two viruses. Respiratory viruses in single viral coinfection cases with SARS-CoV-2 were as follows: non-SARS-CoV-2 coronaviruses (229E, NL63, and OC43, N = 5, 1.9%), rhinovirus (N = 4, 1.6%), metapneumovirus (N = 3, 1.2%), influenza A (N = 3, 1.2%), respiratory syncytial virus A and B (N = 3, 1.2%), and adenovirus (N = 2, 0.8%). No mixed coinfections with respiratory viruses and M. pneumonia e were found. In conclusion, the diagnostic value of utilizing NPS/OPS specimen is excellent, and, as the first report in Korea, coinfection with respiratory pathogens were detected at a rate of 9.7% in patients with COVID-19.Keywords
All Related Versions
- Published version: Canadian Journal of Infectious Diseases and Medical Microbiology, 2021, 1.
This publication has 21 references indexed in Scilit:
- The microbial coinfection in COVID-19Applied Microbiology and Biotechnology, 2020
- Co-infections in people with COVID-19: a systematic review and meta-analysisJournal of Infection, 2020
- Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?Journal of Microbiology, Immunology and Infection, 2020
- Co-infection with respiratory pathogens among COVID-2019 casesVirus Research, 2020
- Influenza and COVID‐19 coinfection: Report of six cases and review of the literatureJournal of Medical Virology, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Rates of Co-infection Between SARS-CoV-2 and Other Respiratory PathogensJAMA, 2020
- Viral load of SARS-CoV-2 in clinical samplesThe Lancet Infectious Diseases, 2020
- The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, ChinaJournal of Medical Virology, 2020
- Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patientsScience China Life Sciences, 2020